The lack of news continues as well as a generally weak market. While it certainly was not strong yesterday (and to start today), it feels more like indifference than a.
Not a lot of news this morning so I will keep it quick. We will have some earnings but large pharma tends to not be a leading indicator for biotech.
I think we are entering a lull in the sector as we are approaching earnings seasons. In general, this tends to be a better season than the first but that.
So I stay away and the sector does well and now that I am back, let us see how it does. I apologize for any weakness that my return causes.
I tried to hold out as much hope for the sector as possible but the selling has been non-stop since the false breakout. The first bit of selling made sense.
Yesterday was a brutal day and the odds now favor it being a false breakout of the sector. I would not say all is lost as if we can bounce.
Sector strength continued and is clearly outperforming the broader market. While we have seen this happen for a couple days before, this feels more like a real breakout. Ideally, we.
The trade war is taking a lot of the headlines and I am running out of time to write as they are replacing my computer soon, which will likely take.
EHA is here and there will be some updates that are of interest but for the most part, I do not see it as having a fundamental effect on the.
Nothing too exciting in terms of market action yesterday. There was some relatively outperformance of large caps versus small caps but that was mainly due to the gene therapy carnage..
The sector did a little better yesterday but given the strength of the market, it is not a great performance. That being said another couple days in the green and.
Despite the lack of any real thesis changing news, ASCO seemed to be fairly typical. There will be a couple of big winners but more losers as you have both.
Some interesting news as we head into ASCO. While the trading action is a little better for the sector it is not exactly tearing it up. Of course, the lack.
We end the week as we started the week with not a lot of news and basically in a holding pattern for ASCO. Hopefully the sector does better today than.
This looks to be a macro day for the markets with I believe China fears percolating again. Unfortunately, these macro down days seem to hit the sector whereas the macro.
So it looks like the trade war with China is off, which should be good for the market in general. Whether that risk on appetite will translate into the biotech.
Some interesting moves and data coming out of the ASCO abstracts. There are some questions answered with these abstracts, although more questions remain unanswered. I suspect that many of the.